Europe Tissue Sectioning Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product [Instruments (Rotary Microtome, Ultramicrotome, Cryostat, Sliding Microtome, and Others), Accessories and Consumables, and Services], Technology (Automatic, Semiautomatic, and Manual), Application (Diagnosis, and Research), and End User (Hospitals, Clinics, Diagnostic Laboratories, Digital Path Labs, and Others)


No. of Pages: 146    |    Report Code: TIPRE00026836    |    Category: Life Sciences

Europe Tissue Sectioning Market
Buy Now

Market Introduction

Tissue sectioning is a procedure that involves cutting tissues into thin sections so that they can be placed on a slide and then mounted under a microscope for study. It is used to examine tissue in order to detect any abnormalities or disease conditions. It is employed in histology laboratories, science laboratories, and other settings. Tissue processing is carried out after it has been examined between tissue embedding and fixation. Frozen sectioning and paraffin sectioning are the two types of tissue sectioning. It is used to detect breast nodules to determine whether a mastectomy is necessary, as well as to treat congenital megacolon in children and newborns. For advanced analysis, the tissues to be sectioned must be cut into very thin pieces or sections, i.e., 5-10 micrometer or smaller portions.

 


Get more information on this report

Europe Tissue Sectioning Strategic Insights

Strategic insights for the Europe Tissue Sectioning provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-tissue-sectioning-market-strategic-framework.webp
Get more information on this report

Europe Tissue Sectioning Report Scope

Report Attribute Details
Market size in 2021 US$ 169.87 Million
Market Size by 2028 US$ 256.26 Million
Global CAGR (2021 - 2028) 6.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Instruments
  • Accessories & Consumables
  • Services
By Technology
  • Automatic
  • Semiautomatic
  • Manual
By Application
  • Diagnosis
  • Research
By and End User
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Digital Path Labs
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC, INC.
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Diapath S.p.A
  • Histo-Line Laboratories
  • SLEE medical GmbH
  • Abcam Plc
  • Amos Scientific Pty Ltd
  • SAKURA FINETEK EUROPE B.V
  • MEDITE Medical GmbH
  • LLS ROWIAK LaserLabSolutions GmbH
  • Get more information on this report

    Europe Tissue Sectioning Regional Insights

    The geographic scope of the Europe Tissue Sectioning refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-tissue-sectioning-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    Personalized or precision medicine has become the hallmark of treatment for various severe diseases and has expanded to other fields with its application. It is a constantly emerging approach to customizing therapies based on patients' genetic accumulation. These technological advancements have led to tissue sectioning approaches that achieve better results with the available resources in less time. For the prevention and efficient treatment of a disease, personalized medicines are mandatory tools, especially in oncology and nephrology cases.

    The rapidly increasing cancer cases indirectly contribute to this market. For instance, as per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million demises in 2020. The most common types of cancer are lung cancer, liver cancer, blood cancer, and breast cancer. Between 30% and 50% of cancers can currently be prevented through early cancer diagnosis and appropriate treatment and care of patients. According to the WHO, several types of cancers are likely to be cured if diagnosed early and treated appropriately. The increasing use of personalized medicine has prompted the use of human tissue use to foster innovative tests.

    Countries in the European region have been significantly affected due to the COVID-19 pandemic. Histopathology & cytopathology sample handling protocols have been changed. In the article Journal of Histotechnology from Informa UK Limited, Coronavirus disinfection in histopathology has emphasized the sample handling procedures for all healthcare experts. The Guidelines from OSHA (Occupational Safety and Health Administration) Bloodborne Pathogens guidelines and the World Health Organization (WHO) recommendations, the precautions to ensure maximum protection while handling specimens received in the laboratory.

    Moreover, all precautions are taken to prevent exposure to the virus. A European perspective research study was conducted on cellular pathology in the COVID-19 era on maintaining quality and safety. This report highlights that the COVID-19 pandemic significantly impacted diagnostic laboratories, particularly those that handled cells and tissue specimens, and recommended suggestions. For instance, specimen handling, processing, and analysis should transport in transport boxes, and all surfaces and equipment be cleaned with an appropriate disinfectant. Therefore, the demand for tissue sectioning in the Europe market is likely to grow slower during COVID -19 situation, owing to the government initiatives in tissue sectioning research.

     

    Key Market Segments

    Based on the product, the Europe tissue sectioning market is segmented into instruments, accessories & consumables, and services. The instruments segment is further sub-segmented into rotary microtome, ultramicrotome, cryostat, sliding microtome, and others. In 2021, the instruments segment held the largest market share, and the accessories & consumables segment is expected to grow at the fastest CAGR during the forecast period.

    Based on the technology, the Europe tissue sectioning market is segmented into automatic, semiautomatic, and manual. The automatic technology segment held the largest share of the market in 2021, and the same segment is estimated to register the highest CAGR in the market during the forecast period.

    By application, the Europe tissue sectioning market is segmented into diagnosis and research. In 2021, the diagnosis segment accounted for the largest share of the market. Moreover, the research segment is expected to witness the fastest CAGR from 2021 to 2028.

    Based on the end user, the Europe tissue sectioning market is segmented into hospitals, clinics, diagnostic laboratories, digital path labs, and others. In 2021, the hospitals segment accounted for the largest share of the market. However, the diagnostic laboratories segment is also expected to grow in demand at the fastest CAGR from 2021 to 2028.

     

    Major Sources and Companies Listed

    Some of the primary and secondary sources associated with this report on the Europe tissue sectioning market are the European Chemical Agency (ECHA), Occupational Safety and Health Administration (OSHA), and the Italian Association for Cancer Research (AIRC).

     

    Reasons to buy the report

    • Determine prospective investment areas based on a detailed trend analysis of Europe tissue sectioning market over the next years.
    • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
    • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
    • Identify the major channels driving the Europe tissue sectioning market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
    • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe tissue sectioning market.

     

    EUROPE TISSUE SECTIONING MARKET SEGMENTATION

    By

    Product

    • Instruments
      • Rotary Microtome
      • Ultramicrotome
      • Cryostat
      • Sliding Microtome
      • Others
    • Accessories and Consumables
    • Services

    By

    Technology

    • Automatic
    • Semi-Automatic
    • Manual

    By Application

    • Diagnosis
    • Research

    By End User

    • Hospitals
    • Clinics
    • Diagnostic Laboratories
    • Digital Path Labs
    • Others

    By Country

    • UK
    • Germany
    • France
    • Italy
    • Spain

    Company Profiles

    • THERMO FISHER SCIENTIFIC, INC.
    • Leica Biosystems Nussloch GmbH (Danaher)
    • Diapath S.p.A
    • Histo-Line Laboratories
    • SLEE medical GmbH
    • Abcam Plc
    • Amos Scientific Pty Ltd
    • SAKURA FINETEK EUROPE B.V
    • MEDITE Medical GmbH
    • LLS ROWIAK LaserLabSolutions GmbH

    The List of Companies - Europe Tissue Sectioning Market

    1. THERMO FISHER SCIENTIFIC, INC.
    2. Leica Biosystems Nussloch GmbH (Danaher)
    3. Diapath S.p.A
    4. Histo-Line Laboratories
    5. SLEE medical GmbH
    6. Abcam Plc
    7. Amos Scientific Pty Ltd
    8. SAKURA FINETEK EUROPE B.V
    9. MEDITE Medical GmbH
    10. LLS ROWIAK LaserLabSolutions GmbH
    Frequently Asked Questions
    How big is the Europe Tissue Sectioning Market?

    The Europe Tissue Sectioning Market is valued at US$ 169.87 Million in 2021, it is projected to reach US$ 256.26 Million by 2028.

    What is the CAGR for Europe Tissue Sectioning Market by (2021 - 2028)?

    As per our report Europe Tissue Sectioning Market, the market size is valued at US$ 169.87 Million in 2021, projecting it to reach US$ 256.26 Million by 2028. This translates to a CAGR of approximately 6.0% during the forecast period.

    What segments are covered in this report?

    The Europe Tissue Sectioning Market report typically cover these key segments-

    • Product (Instruments, Accessories & Consumables, Services)
    • Technology (Automatic, Semiautomatic, Manual)
    • Application (Diagnosis, Research)
    • and End User (Hospitals, Clinics, Diagnostic Laboratories, Digital Path Labs)

    What is the historic period, base year, and forecast period taken for Europe Tissue Sectioning Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Tissue Sectioning Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Tissue Sectioning Market?

    The Europe Tissue Sectioning Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC, INC.
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Diapath S.p.A
  • Histo-Line Laboratories
  • SLEE medical GmbH
  • Abcam Plc
  • Amos Scientific Pty Ltd
  • SAKURA FINETEK EUROPE B.V
  • MEDITE Medical GmbH
  • LLS ROWIAK LaserLabSolutions GmbH
  • Who should buy this report?

    The Europe Tissue Sectioning Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Tissue Sectioning Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now